PR90500

NEW YORK and LONDON and HONG KONG, July 8, 2021 /PRNewswire=KYODO JBN/ --

-- Firm doubles down in region following record growth in APAC as Chinese

market further opens up

Enfusion (

https://c212.net/c/link/?t=0&l=en&o=3219123-1&h=2909008023&u=https%3A%2F%2Fwww.enfusionsystems.com%2F&a=Enfusion

), the leading provider of cloud-based investment management software and

services, announced today that they have formed a wholly foreign-owned

enterprise (WFOE) in China (Enfusion (Shanghai) Co., Ltd "Enfusion Shanghai"),

marking the first official step in the firm's expansion into mainland China.

Logo - https://mma.prnewswire.com/media/660825/ENFUSION_Logo.jpg  

Establishing Enfusion Shanghai reaffirms Enfusion's long-term commitment to

serving investment managers in Asia-Pacific (APAC) and positions Enfusion to

support the increasing demand among institutional and alternative investment

management firms for robust digital platforms to support domestic and global

investments. APAC investment managers are committed to enhancing their

technology stacks with solutions that mitigate risk and unlock efficiencies

across their enterprise, as evident from Enfusion's signing and onboarding of

24 new fund managers in APAC so far this calendar year, including 10 offshore

funds of Chinese investors. Operating through Enfusion Shanghai, Enfusion will

be able to extend its best in class SaaS product to serve mainland investment

managers as well.

"After a record year of growth in the APAC region, Enfusion established

Enfusion Shanghai to respond to the increasing demand for innovative, digital

solutions among mainland Chinese and global investment managers," said Thomas

Kim, CEO of Enfusion. "We have been catering to the offshore Chinese market for

years, helping our clients solve evolving and complex challenges with our cloud

native-platform and managed services solutions. We are thrilled to be taking

this next step in our journey and bring our best in class offering, which has

been disrupting the global asset management ecosystem, to the mainland."

The market size and sustained growth of the mainland China market has

established itself as a priority region in the global capital markets. At the

same time, regulation in China continues to open up, encouraging onshore

investors to extend their footprint globally and attracting offshore investors.

As such, a new wave of operational challenges has emerged where many Chinese

and global managers now find their systems unable to accommodate the diverse

nature of their onshore and offshore investments, forcing them to use disparate

systems which are cumbersome, error-prone, and take valuable time away from the

investment process. Enfusion has proven to be uniquely positioned in addressing

such challenges globally, and will serve the Chinese market with the

front-to-back office SaaS offering that provides the accuracy, transparency,

and efficiencies needed to support rapid international expansion.

Driving the entry into the Chinese market, including the setup of Enfusion

Shanghai, is Iris Xinwei Wang, who recently joined Enfusion as Global Head of

Strategy. Iris will oversee Enfusion's global strategy and leverage her native

expertise to grow Enfusion's client base and partnership in mainland China.

Wang brings with her over twelve years of strategy expertise, including six

years at Bridgewater Associates in strategy and business planning, and prior

with Boston Consulting Group on market entry and global growth strategies. Wang

has a Bachelor of Science in Finance from Fudan University and a Master of

Business Administration from Harvard Business School.

About Enfusion

Enfusion's investment management software-as-a-service platform removes

traditional information boundaries, uniting front, middle and back-office teams

on one cloud native system and across one golden data set. Through our

industry-leading software, analytics, and middle/back-office managed services,

we create enterprise-wide cultures of real-time, data-driven intelligence,

boosting agility, and powering growth.

As a Fintech leader and pioneer in developing innovative solutions, Enfusion

partners with 600+ investment managers from nine global offices spanning four

continents. In 2020, HFM named Enfusion as the "Best Overall Technology Firm",

"Best Trading & Execution Technology", "Best Integrated Solution" and "Best

Managed Services Provider". For more information about its technology and

Managed Services capabilities visit: https://www.enfusion.com/.

SOURCE  Enfusion Systems

Media Contact: Lorelei Skillman, Chief Marketing Officer,

lorelei.skillman@enfusion.com